| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $53,285,644 ) (Continued on the next page) |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01GM144729 | Acylations: a novel pathway in the response to mitochondrial energy dysfunction | 000 | 2 | NIH | 11/23/2022 | $281,700 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R37AI112787 | Targeting PD-1 Pathway for Functional Cure of AIDS | 000 | 10 | NIH | 12/22/2022 | $807,098 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01HL158141 | Diversity Supplement to Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women | 000 | 2 | NIH | 1/13/2023 | $46,410 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AG072309 | Engineered Heterochronic Parabiosis on 3D Microphysiological Systems | 000 | 4 | NIH | 1/20/2023 | $382,367 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH126195 | Leveraging 3D bioprinted organoid constructs to pattern and model human brain development | 000 | 3 | NIH | 1/18/2023 | $617,025 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01DA052909 | Early Life Stress, Chronic Drug Use and Neuroplasticity in Nonhuman Primate Models of Cocaine Abuse: Relevance to Treatment Strategies | 000 | 3 | NIH | 1/26/2023 | $808,680 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21EB029622 | Improved non-invasive MR brain thermometry for therapeutic hypothermia | 000 | 3 | NIH | 12/28/2022 | $195,000 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AI162267 | HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles | 000 | 3 | NIH | 1/19/2023 | $909,998 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | F32CA257436 | Role of phosphate availability in lung cancer invasion and bone metastasis | 000 | 3 | NIH | 1/5/2023 | $78,550 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AG070937 | The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | 000 | 3 | NIH | 1/26/2023 | $7,011,679 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R35GM139408 | Nuclear Organization and Function | 000 | 3 | NIH | 1/6/2023 | $476,165 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K23AG066931 | Association of Perceived Stress and Cognition | 000 | 3 | NIH | 1/17/2023 | $179,388 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AG067736 | High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease | 000 | 3 | NIH | 1/23/2023 | $566,543 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AI153071 | Proteolytic regulation of the Streptococcus pyogenes cell surface | 000 | 3 | NIH | 12/8/2022 | $382,168 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01CA257861 | Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis | 000 | 3 | NIH | 1/25/2023 | $532,237 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01NS120182 | Neurodevelopment after postnatal Zika virus infection in infant macaques | 000 | 3 | NIH | 12/7/2022 | $662,604 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01HL152322 | Diffuse optical spectroscopies to assess cerebral hemodynamics in pediatric sickle cell disease | 001 | 3 | NIH | 1/11/2023 | $431,236 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | F31ES031845 | Transgenerational epigenetic inheritance of obesity | 000 | 3 | NIH | 1/10/2023 | $46,752 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | F31HL156495 | The Consequence of Impaired Lymphatic Drainage on Rejection in Cardiac Transplantation | 000 | 3 | NIH | 12/26/2022 | $46,752 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01HL155330 | Leveraging platelet contraction cytometry for immune thrombocytopenia | 000 | 3 | NIH | 1/5/2023 | $346,545 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K01HL155235 | N-methyl-D-aspartate receptors (NMDAr) participates in renal hemodynamic regulation and blood pressure homeostasis | 000 | 3 | NIH | 1/13/2023 | $104,450 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AG062581 | Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease | 000 | 4 | NIH | 1/13/2023 | $460,970 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R35GM136407 | Theoretical and Experimental Studies of the Population and Evolutionary Dynamics of Bacteria and Bacteriophage. | 000 | 4 | NIH | 1/16/2023 | $351,000 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AI148471 | Epigenetic instruction of memory B cell function and reactivation | 000 | 4 | NIH | 11/30/2022 | $387,022 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21CA266088 | Modulation of the human pancreatic microenvironment by combined cytokine and immune checkpoint blockade | 000 | 2 | NIH | 12/21/2022 | $164,619 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01HL160589 | Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure | 000 | 2 | NIH | 1/13/2023 | $390,755 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH128130 | STI Response and Recommendations Under PrEP (STIRRUP) | 000 | 2 | NIH | 12/15/2022 | $535,241 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21NS116639 | MET kinase fusions in pediatric glioblastoma | 000 | 2 | NIH | 12/21/2022 | $176,063 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21AI167032 | flowBEAT:?a multiparameter flow cytometry assay to discover?longitudinal antibody responses associated with efficient recovery from COVID-19 | 000 | 2 | NIH | 11/1/2022 | $192,880 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AI165644 | Impact of intra-host population structure on influenza virus antigenic evolution | 000 | 2 | NIH | 11/22/2022 | $386,255 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH128130 | STI Response and Recommendations Under PrEP (STIRRUP) | 001 | 2 | NIH | 1/19/2023 | $59,471 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21NS116639 | MET kinase fusions in pediatric glioblastoma | 001 | 2 | NIH | 12/23/2022 | $37,560 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R34MH129187 | Brothers building brothers by breaking barriers (B6): A resilience-focused intervention for young Black gay and bisexual men living with HIV | 000 | 2 | NIH | 11/15/2022 | $211,163 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R03TR004022 | Endogenous Cannabinoids in Inflammatory Airway Disease | 000 | 2 | NIH | 12/8/2022 | $70,425 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K23NR020208 | A Behavioral Intervention to Reduce Psychological Distress Symptoms among Black Gender Minority Women Experiencing Chronic Stigma | 000 | 2 | NIH | 12/22/2022 | $162,310 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21DE030632 | Determining Host-microbiome guided oro-nasal fistula healing | 000 | 2 | NIH | 12/19/2022 | $175,722 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01NR020334 | A Web-App Based Lifestyle Physical Activity Promotion Program to Improve Depressive Symptom Experience: Midlife Korean American Women | 000 | 2 | NIH | 1/20/2023 | $544,471 |
| 2023 | 2023 | EMORY UNIVERSITY | 1599 Clifton Rd NE, #4 | Atlanta | GA | 30322-4250 | DEKALB | USA | U3N45397 | Health and Public Safety Workforce Resiliency Training Program | 00 | 2 | HRSA | 11/15/2022 | $709,000 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | U01DA056000 | SARS-CoV-2 in Correctional Populations: A collaborative, ethical approach to application of wastewater-based surveillance | 000 | 2 | NIH | 12/8/2022 | $638,186 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21DE030632 | Determining Host-microbiome guided oro-nasal fistula healing | 001 | 2 | NIH | 1/24/2023 | $0 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01HL157323 | Using Modern Data Science Methods and Advanced Analytics to Improve the Efficiency, Reliability, and Timeliness of Cardiac Surgical Quality Data | 000 | 2 | NIH | 12/1/2022 | $677,235 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01ES032440 | Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | 000 | 2 | NIH | 11/29/2022 | $348,038 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01ES032440 | Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | 001 | 2 | NIH | 11/30/2022 | $0 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R03CA267456 | Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors | 000 | 2 | NIH | 11/18/2022 | $83,883 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH126083 | Glutamatergic adaptation to stress as a mechanism for anhedonia and treatment response with ketamine | 000 | 2 | NIH | 12/19/2022 | $686,107 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01ES033603 | Gene-Environment interactions in Autism | 000 | 2 | NIH | 11/30/2022 | $611,016 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | U01MD018313 | Increasing representation of Black communities in COVID-19 home testing and surveillance data | 000 | 1 | NIH | 10/31/2022 | $570,231 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R13AI174629 | RespiDART 2022: Frontiers in Drug Development against Respiratory Viruses | 000 | 1 | NIH | 11/29/2022 | $6,500 |
| 2023 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | F31CA247564 | Automated imaging analysis tools to guide clinical decision making in brain tumor patients | 000 | 4 | NIH | 11/29/2022 | $46,752 |
|